Study of AGN1 LOEP bone treatment outcomes in hip
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism, Injuries & trauma, Skin clinical trials.
This study looks back at how well AGN1 LOEP—a bone-strengthening treatment—worked for people who received it in their hip bone. Researchers want to understand real-world results to help future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received AGN1 LOEP treatment in your upper thighbone (proximal femur) between September 2019 and January 2026
- You are able and willing to give written permission for researchers to review your medical records
- Your AGN1 LOEP treatment was not part of a previous AgNovos clinical trial study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies AGN1 LOEP, a treatment being tested to improve bone strength in people with osteoporosis-related bone loss in the hip. If you qualify, you would be followed over time with clinic visits and testing to see how the treatment affects your bone health.
This trial tests AGN1 LOEP (a medicine/device placed at the hip surgery site) to help prevent another hip fracture after you’ve had a low-energy hip fracture. You must be eligible for hip repair surgery and be at higher risk for another fracture, with no key exclusions like active cancer or serious kidney disease.
This study looks at people with osteoporotic hip fractures (breaks in the femur near the hip) and evaluates their care and outcomes. It may help improve how hip fractures are treated in people whose bones are weaker due to osteoporosis.
This study collects information and samples around the time of certain bone or joint surgeries (like joint replacement or fracture repair) to learn what factors help or harm bone healing. The results may help find better targets to improve long-term bone health and recovery.
This trial uses scans like X-rays, CT, or MRI to study how bones and joints age. It aims to understand aging-related problems and may help develop better ways to detect or treat them.
This trial tests whether injecting your own bone marrow into the hip can help heal early-stage osteonecrosis (bone death) before the bone collapses. It is for people who have not had prior hip surgery and do not have certain conditions like sickle cell disease.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.